TTD | Drug: D0IX1V

Drug General Information
Drug ID	D0IX1V
Former ID	DNC013654
Drug Name	1-(10-Bromoanthracen-9-yl)-2-aminopropane
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529336]
Structure		Download 2D MOL 3D MOL
Formula	C17H16BrN
Canonical SMILES	CC(CC1=C2C=CC=CC2=C(C3=CC=CC=C31)Br)N
InChI	1S/C17H16BrN/c1-11(19)10-16-12-6-2-4-8-14(12)17(18)15-9-5-3-7-13(15)16/h2-9,11H,10,19H2,1H3
InChIKey	TUYLBDQSCRSJBH-UHFFFAOYSA-N
PubChem Compound ID	24939279
Target and Pathway
Target(s)	5-hydroxytryptamine 2A receptor	Target Info	Inhibitor	[529336]
KEGG Pathway	Calcium signaling pathway
	Neuroactive ligand-receptor interaction
	Gap junction
	Serotonergic synapse
	Inflammatory mediator regulation of TRP channels
PANTHER Pathway	5HT2 type receptor mediated signaling pathway
Reactome	Serotonin receptors
Reactome	G alpha (q) signalling events
WikiPathways	Serotonin Receptor 2 and STAT3 Signaling
	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
	SIDS Susceptibility Pathways
	Monoamine GPCRs
	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	GPCR ligand binding
	GPCR downstream signaling
	GPCRs, Other
References
Ref 529336	Bioorg Med Chem. 2008 Apr 15;16(8):4661-9. Epub 2008 Feb 14.The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.
Ref 529336	Bioorg Med Chem. 2008 Apr 15;16(8):4661-9. Epub 2008 Feb 14.The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information